It acts as a coactivator of nuclear hormone receptors such as AR and ER, thereby promoting the progression of prostate and breast cancers by enhancing histone modifications and transcriptional activation at hormone-responsive elements (28, 29, 45). This evidence concerns the gene NR0B1 and breast carcinoma.